Skip to main content
Year archive

Bio Solution Co.,Ltd. — 2019 filings

All 31 regulatory filings released by Bio Solution Co.,Ltd. (086820) in 2019, sourced directly from the official regulator.

31 Filings
2019 Period
2019 filings (31)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2019-12-13 Korean
투자판단관련주요경영사항(관절연골재생용 세포치료제 카티라이프의 미국 FDA(식품의약국) 2상 임상시험계획 승인)
Regulatory Filings
2019-11-15 Korean
분기보고서 (2019.09)
Interim / Quarterly Report 9M 2019
2019-11-14 Korean
기업설명회(IR)개최
Investor Presentation
2019-10-14 Korean
기타경영사항(자율공시)(카티라이프(바솔자가연골유래연골세포)의 임상3상 시험 계획 승인)
Regulatory Filings
2019-09-25 Korean
기타경영사항(특허권취득)(자율공시)(물질 P를 포함하는 상처치유용 약학 조성물)
Regulatory Filings
2019-09-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2019-08-30 Korean
기업설명회(IR)개최
Regulatory Filings
2019-08-14 Korean
반기보고서 (2019.06)
Interim / Quarterly Report H1 2019
2019-08-14 Korean
분기보고서 (2019.03)
Interim / Quarterly Report Q1 2019
2019-05-15 Korean
기타경영사항(자율공시)
Regulatory Filings
2019-04-24 Korean
기타경영사항(특허권취득)(자율공시)(구슬형 연골세포 치료제의 제조방법(유럽특허등록))
Regulatory Filings
2019-04-17 Korean
기업설명회(IR)개최
Investor Presentation
2019-04-11 Korean
[기재정정]사업보고서 (2018.12)
Annual Report FY 2018
2019-04-10 Korean
대표이사변경
Board/Management Information
2019-03-29 Korean
본점소재지변경
Regulatory Filings
2019-03-29 Korean
[첨부추가]사업보고서 (2018.12)
Audit Report / Information FY 2018
2019-03-28 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2019-03-27 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2019-03-25 Korean
감사보고서제출
Audit Report / Information FY 2018
2019-03-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2019-03-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2019-03-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2019-03-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2019-03-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2019-03-13 Korean
주주총회소집공고
AGM Information
2019-03-08 Korean
주식매수선택권행사
Share Issue/Capital Change
2019-02-22 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2019-02-12 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2019-02-12 Korean
기타경영사항(특허권취득)(자율공시)
Regulatory Filings
2019-01-29 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2018
2019-01-18 Korean